Angiomyolipoma — Trials

Angiomyolipoma — Trials · CancerIndex

Clinical trials

Registered studies

10 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–5 of 5 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02325505	Characterization of Patients With Tuberous Sclerosis Complex, Lymphangioleiomyomatosis and Angiomyolipoma	completed	—	200	InCor Heart InstituteOTHER	1	Aug 4, 2022	clinicaltrials
NCT00126672	RAPAMYCIN FOR KIDNEY ANGIOMYOLIPOMAS	completed	Phase 2	36	Dana-Farber Cancer InstituteOTHER	1	Apr 25, 2022	clinicaltrials
NCT03525834	Safety and Efficacy of Everolimus (Afinitor®) in Chinese Adult Patients With Angiomyolipoma Associated With Tuberous Sclerosis Complex.	completed	Phase 4	40	Novartis PharmaceuticalsINDUSTRY	1	Sep 9, 2021	clinicaltrials
NCT03477149	EASYX-1 : A Multicenter Study on Safety and Efficacy of Easyx Liquid Embolization Agent Used in Five Separate Indications

Data updated 22 days agoSource updated Aug 4, 2022source: clinicaltrials